Literature DB >> 14533200

DNA transfection of mononuclear cells in muscle tissue.

Eirik Grønevik1, Stig Tollefsen2, Liv Ingunn Bjoner Sikkeland3, Terje Haug3, Torunn Elisabeth Tjelle4, Iacob Mathiesen4.   

Abstract

BACKGROUND: Genes encoding non-self proteins may be injected into skeletal muscles in vivo to obtain induction of cellular and humoral immune responses against the encoded antigens (DNA vaccination). Bone marrow derived professional antigen-presenting cells (APCs) play a key role in the induction of immunity by DNA vaccination. In the present work we have investigated whether the APCs are transfected by DNA injection into muscle.
METHODS: DNA encoding green fluorescent protein (GFP) was injected into rat and mouse limb muscle and followed by electroporation. Whole mount muscle tissue with GFP-positive mononuclear cells (MNCs) were treated with immunocytochemical markers specific for leukocytes, and studied with fluorescent microscopy. To detect transfected cells migrating to peripheral lymphoid tissue RT-PCR was applied on RNA isolated from the draining popliteal lymph node and spleen. Lymphoid tissue was also analyzed with real-time PCR for distribution of the injected plasmid.
RESULTS: MNCs were transfected after intramuscular DNA injection, and, following DNA injection with electroporation, the number of GFP-positive MNCs increased 6-fold in rats and 14-fold in mice. None of the GFP-positive MNCs were stained with leukocyte-specific antibodies. Even though GFP encoding DNA was detected in the popliteal lymph node, no RNA encoding GFP was found in the lymph node or spleen. However, MHC II-positive cells in the muscle tissue appeared preferentially around the transfected MNCs.
CONCLUSIONS: Many MNCs in the muscle are transfected after intramuscular DNA injection. Electroporation significantly increases the number of transfected MNCs. None of the observed transfected MNCs however were leukocytes. MHC II-positive cells accumulated around transfected MNCs; this suggests that transfer of antigen from transfected MNCs to APCs may contribute to the immune response. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14533200     DOI: 10.1002/jgm.416

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  10 in total

1.  Transgene expression and local tissue distribution of naked and polymer-condensed plasmid DNA after intradermal administration in mice.

Authors:  R Noelle Palumbo; Xiao Zhong; David Panus; Wenqing Han; Weihang Ji; Chun Wang
Journal:  J Control Release       Date:  2012-01-24       Impact factor: 9.776

2.  Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation.

Authors:  Jinyan Liu; Rune Kjeken; Iacob Mathiesen; Dan H Barouch
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

3.  Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer.

Authors:  C Trollet; Y Pereira; A Burgain; E Litzler; M Mezrahi; J Seguin; M Manich; M R Popoff; D Scherman; P Bigey
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

4.  Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques.

Authors:  Amara Luckay; Maninder K Sidhu; Rune Kjeken; Shakuntala Megati; Siew-Yen Chong; Vidia Roopchand; Dorys Garcia-Hand; Rashed Abdullah; Ralph Braun; David C Montefiori; Margherita Rosati; Barbara K Felber; George N Pavlakis; Iacob Mathiesen; Zimra R Israel; John H Eldridge; Michael A Egan
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

5.  Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging.

Authors:  Stefan P Petkov; Frank Heuts; Olga A Krotova; Athina Kilpelainen; Gunnel Engström; Elizaveta S Starodubova; Maria G Isaguliants
Journal:  Hum Vaccin Immunother       Date:  2013-07-03       Impact factor: 3.452

6.  DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica.

Authors:  Yang Dai; Yinchang Zhu; Donald A Harn; Xiaoting Wang; Jianxia Tang; Song Zhao; Fei Lu; Xiaohong Guan
Journal:  Clin Vaccine Immunol       Date:  2009-10-07

7.  Targeting Muscle-Resident Single Cells Through in vivo Electro-Enhanced Plasmid Transfer in Healthy and Compromised Skeletal Muscle.

Authors:  Francesca Florio; Silvia Accordini; Michela Libergoli; Stefano Biressi
Journal:  Front Physiol       Date:  2022-04-01       Impact factor: 4.755

8.  DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response.

Authors:  Trevor Rf Smith; Katherine Schultheis; William B Kiosses; Dinah H Amante; Janess M Mendoza; John C Stone; Jay R McCoy; Niranjan Y Sardesai; Kate E Broderick
Journal:  Mol Ther Methods Clin Dev       Date:  2014-12-03       Impact factor: 6.698

9.  DNA vaccines: MHC II-targeted vaccine protein produced by transfected muscle fibres induces a local inflammatory cell infiltrate in mice.

Authors:  Tom-Ole Løvås; Jo C Bruusgaard; Inger Øynebråten; Kristian Gundersen; Bjarne Bogen
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

10.  A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen.

Authors:  Catherine M Rush; Timothy J Mitchell; Paul Garside
Journal:  Vaccine       Date:  2009-12-23       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.